menu ☰
menu ˟

Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose

Creator:

Van da Laar, F. et al

Subject Keywords: Alpha-glucosidase inhibitors, Blood glucose
Topic: Chronic Conditions
Conditions
Coronary Heart Disease (CHD)
Diabetes
Hypertension
Stroke
Chronic Conditions
Type: Article
Region: International (other)
Description:

Alpha-glucosidase inhibitors (AGIs) reduce blood glucose levels and may thus prevent type 2 diabetes and cardiovascular disease in patients with impaired glucose tolerance (IGT). These possible effects, and the effects on quality of life, plasma lipids and body weight, have never been investigated in a systematic literature review and meta-analysis.The objective of this review is to assess the effects of alpha-glucosidase inhibitors in patients IGT or impaired fasting blood glucose (IFBG), or both.

Date:

21/01/2009

Rights: © The Cochrane Collaboration
Suggested citation:

Van da Laar, F. et al. (2009) Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose [Online]. Available from: http://publichealthwell.ie/node/96265 [Accessed: 17th June 2019].

  

View your saved citations and reading lists

Contributor:

Other partner websites
 
Click here to view all the resources gathered from this organisation's website.